OMEN-1 has been shown to exert anti-inflammatory effects, and the expression of the omentin gene and serum levels of omentin are lower in obese people, correlating negatively with measures such as waist circumference, BMI, IR and glucose intolerance. The gene discussed is ITLN1; the disease is Glucose intolerance.